Friday 6 November 2026 Export ROIV’s income statement to Excel — free account

Roivant Sciences Ltd.

ROIV Healthcare Biotechnology

Roivant Sciences Ltd.’s revenue for fiscal 2026 (year ended March 2026) was $8.3 million, down 71.6% from fiscal 2025.

Revenue: −33.6%
EPS: +21.2%
Free cash flow: −30.0%

Quarter to June 2026, against a year earlier

38.90 2.28 +6.23%

Follow ROIV

Alert me

Market cap: $26.5B
P/E: 0.0×
Fwd P/E: −27.7×
Dividend yield: —
F-score: 2/9
Altman Z: 28.31
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Roivant Sciences Ltd. (ROIV) P/E ratio

Alert me on P/E ratio

Roivant Sciences Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 2.2× (April 2024) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ROIV/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Roivant Sciences Ltd. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ROIV/metrics/pe-ratio">Roivant Sciences Ltd. (ROIV) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2026	0.0×	—
FY2025	0.0×	—
FY2024	1.9×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
Sep 2025	0.0×	—
21 more quarters	Free account

Against its own ten years

Low 0.0× High 2.2×

Ten-year median 0.0×

Current reading's percentile 83

Company	P/E ratio
ROIV Roivant Sciences Ltd.	n/m
BNTX BioNTech SE Sponsored ADR compare	n/m
RVMD Revolution Medicines, Inc. compare	n/m
INSM Insmed, Inc. compare	n/m
ALNY Alnylam Pharmaceuticals, Inc. compare	7.9×
RPRX Royalty Pharma PLC compare	37.6×
GMAB Genmab A/S Sponsored ADR compare	42.2×
INCY Incyte Corporation compare	56.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	68.9×
Biotechnology industry median	10.6×
Healthcare sector median	24.5×
Market median	17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Roivant Sciences Ltd. (ROIV) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ROIV

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ROIV

Stockrow Weekly